10
Publications
929
Citations
10
H-Index
2001
Active since
Xing Li is an author at Pfizer (United States) specializing in medicine, natural sciences, and biochemistry.
Top concepts
MedicineBiochemistryNatural SciencesPharmacologyDrug DiscoveryMolecular BiologyStructural BiologyChemistryProtein FoldingChemical Biology
Publications per year
2001–2021
10
10
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani, F. Forouhar, Hengrui Liu et al. · Nature Communications · 2021 · 108 citations · Full text
Protease Inhibitors, Lead Compounds, Combinatorial Chemistry +13
Rows per page
1–5 of 10